Quantcast

Latest Blood glucose monitoring Stories

2014-05-08 08:33:32

ALBANY, New York, May 8, 2014 /PRNewswire/ -- MRRBIZ includes new market research report "Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems And Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its large collection of research report. This report studies the current scenario as well as the future market potential for...

2014-05-08 08:32:39

Conference Call to begin at 9:00 a.m. EDT PHILADELPHIA, May 8, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it will release its financial results for the quarter ended March 31, 2013 and provide a regulatory and product development update on Friday, May 9, 2014. Management will hold a conference call to review the...

2014-05-07 12:31:10

WASHINGTON, May 7, 2014 /PRNewswire-USNewswire/ -- In January, the U.S. Food and Drug Administration (FDA) released draft guidance proposing separate performance and accuracy criteria for over-the-counter blood glucose meters used in the home and prescription blood glucose meters used in hospitals. AACC supports FDA's initiative to improve the quality of these devices and enhance patient care, but recommends revising this draft guidance to ensure that it does not unnecessarily...

2014-05-05 23:10:01

On April 29, the FDA issued a safety communication advising healthcare professionals and people with diabetes to stop using GenStrip Blood Glucose Test Strips, by Shasta Technologies LLC, because they may report false results. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) May 05, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest...

2014-05-01 08:37:03

Critical intellectual property recognition is a major step in bringing Dario(TM) to market in the U.S. CAESAREA, Israel, May 1, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims covering the company's personalized blood glucose monitoring device. LabStyle's now patent pending invention,...

2014-04-28 08:33:10

600,000 Italians Now Eligible for Reimbursement Coverage CAESAREA, Israel, April 28, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that it has received national approval and regional reimbursement for the Dario(TM) Personalized Smart Meter in Italy. Receipt of reimbursement approvals is a key component of LabStyle's continuing commercial roll out of the Dario(TM) Diabetes Management Solution....

2014-04-28 08:31:53

Pivotal Trial to Build on Previous Positive Studies; Aims to Further Demonstrate Paradigm-Shifting Potential of Automated, Bedside Glucose Monitoring System in the ICU HAYWARD, Calif., April 28, 2014 /PRNewswire/ -- OptiScan Biomedical Corporation, a developer of innovative continuous monitoring systems for use in the intensive care unit (ICU), today announced the enrollment of the first patient in a pivotal, multi-center Investigational Device Exemption (IDE) clinical study of the...

2014-04-25 08:26:55

DUBLIN, April 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zvrjkt/selfcare_medical) have announced the addition of the "Self-Care Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/zvrjkt/selfcare_medical ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Self-care medical devices are...

2014-04-24 16:28:58

ORMD-0801 Oral Insulin Appeared Safe and Well-tolerated. No Hypoglycemic Events or Treatment Related Adverse Events Observed JERUSALEM, April 24, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today detailed results from its previously completed Phase IIa trial investigating ORMD-0801, its orally ingestible insulin capsule, in type 2...

2014-04-24 12:28:58

PORTLAND, Oregon, April 24, 2014 /PRNewswire/ -- The database of Research Beam has a latest addition of report, titled "Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 -2020." This report prepared with insightful analysis provides a microscopic view about continuous glucose monitoring market to...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related